NEMHESYS—European Perspective on the Implementation of Next-generation Sequencing Into Clinical Diagnostics

• Inmaculada Serramito-Gómez,
• Kathryn M. Clarke,
• Ana Eugenia Rodríguez-Vicente,
• Julie E. McGimpsey,
• María Abáigar,
• Carlos Barranquero Díez,
• Rocío Benito,
• Lars Bullinger,
• Ken I. Mills,
• Jesús María Hernández Rivas

Affiliations

Inmaculada Serramito-Gómez

1 Department of Medicine, Cancer Research Centre, University of Salamanca, IBSAL, IBMCC, CSIC, Salamanca, Spain

Kathryn M. Clarke

2 Patrick G. Johnston Centre for Cancer Research, Queen’s University Belfast, United Kingdom

Ana Eugenia Rodríguez-Vicente

1 Department of Medicine, Cancer Research Centre, University of Salamanca, IBSAL, IBMCC, CSIC, Salamanca, Spain

Julie E. McGimpsey

2 Patrick G. Johnston Centre for Cancer Research, Queen’s University Belfast, United Kingdom

María Abáigar

3 Department of Haematology, Oncology, and Tumor Immunology, Charité-Universitätsmedizin Berlin—Campus Virchow-Klinikum, Berlin, Germany

Carlos Barranquero Díez

4 Artelnics, Villamayor, Salamanca, Spain

Rocío Benito

1 Department of Medicine, Cancer Research Centre, University of Salamanca, IBSAL, IBMCC, CSIC, Salamanca, Spain

Lars Bullinger

5 Department of Haematology, Oncology, and Tumor Immunology, Charité-Universitätsmedizin Berlin—Campus Virchow-Klinikum, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Berlin, Germany

Ken I. Mills

2 Patrick G. Johnston Centre for Cancer Research, Queen’s University Belfast, United Kingdom

Jesús María Hernández Rivas

1 Department of Medicine, Cancer Research Centre, University of Salamanca, IBSAL, IBMCC, CSIC, Salamanca, Spain